[Possibilities of reducing the doses of beta-adrenergic bronchodilators (Berotec) in combination with an anticholinergic drug (Atrovent) in bronchial asthma].
D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001286:Atropine Derivatives / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage*; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage*
D001286:Atropine Derivatives; D001993:Bronchodilator Agents; D004338:Drug Combinations; D004983:Ethanolamines; D010276:Parasympatholytics; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D009241:Ipratropium
Posibilităţi de reducere a dozelor de bronhodilatatoare beta-adrenergice (Berotec) prin asociere cu un anticolinergic (Atrovent) în astmul bronşic.